InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-44.6%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by Bruck Claudine, Director. Officer active across 2 companies, notably Navidea Biopharmaceuticals, INC.. In total, 6 reports have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €4k. Activity tracked since 30 June 2021. The latest transaction was filed on 10 September 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bruck Claudine
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
7,142 shares@ US$0.145.2% of flowCommon StockSEC:0001104659-25-109904:0
00Common StockSEC:0001104659-23-120749:0
1,000 shares@ US$6.0727.8% of flowCommon StockSEC:0001104659-23-120299:0
500 shares@ US$12.6128.9% of flowCommon StockSEC:0001104659-23-044208:0
181 shares@ US$27.6626.2% of flowCommon StockSEC:0001415889-21-004864:0
Canonical exit: 9 Jan 2022 (T+90)
3,969 shares0Common StockSEC:0001437749-21-016596:0
6 of 6 declarations
About Bruck Claudine
Claudine Bruck is a Director at NAVIDEA BIOPHARMACEUTICALS, INC. and Annovis Bio, Inc. She brings valuable expertise in the biopharmaceutical field, contributing to the strategy and governance of these companies. Her role as a director allows her to actively participate in strategic decision-making and oversee operations, thereby fostering growth and innovation.
